Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic

The novel coronavirus has swept across the world in 2020 and ushered a new era. In the current scenario, it is not clear how patients with myeloproliferative neoplasms (including chronic myelogenous leukemia) should be managed, considering the risk of therapy, the need for social distancing and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Fabio Pires de Souza, Tavares, Renato Sampaio, Pagnano, Katia Borgia Barbosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2020
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303601/
https://www.ncbi.nlm.nih.gov/pubmed/32654986
http://dx.doi.org/10.1016/j.htct.2020.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303601/
https://www.ncbi.nlm.nih.gov/pubmed/32654986
http://dx.doi.org/10.1016/j.htct.2020.06.005

Ejemplares similares